The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Volume 338:1481-1487 May 21, 1998 Number 21
NextNext

Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease
Lauri A. Aaltonen, M.D., Reijo Salovaara, M.D., Paula Kristo, Ph.D., Federico Canzian, Ph.D., Akseli Hemminki, M.B., Päivi Peltomäki, M.D., Robert B. Chadwick, M.Sc., Helena Kääriäinen, M.D., Matti Eskelinen, M.D., Heikki Järvinen, M.D., Jukka-Pekka Mecklin, M.D., Albert de la Chapelle, M.D., Antonio Percesepe, M.D., Heikki Ahtola, M.D., Niilo Härkönen, M.D., Risto Julkunen, M.D., Eero Kangas, M.D., Seppo Ojala, M.D., Jukka Tulikoura, M.D., and Erkki Valkamo, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Editorial
 by Lynch, H. T.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Genetic disorders that predispose people to colorectal cancer include the polyposis syndromes and hereditary nonpolyposis colorectal cancer. In contrast to the polyposis syndromes, hereditary nonpolyposis colorectal cancer lacks distinctive clinical features. However, a germ-line mutation of DNA mismatch-repair genes is a characteristic molecular feature of the disease. Since clinical screening of carriers of such mutations can help prevent cancer, it is important to devise strategies applicable to molecular screening for this disease.

Methods We prospectively screened tumor specimens obtained from 509 consecutive patients with colorectal adenocarcinomas for DNA replication errors, which are characteristic of hereditary colorectal cancers. These replication errors were detected through microsatellite-marker analyses of tumor DNA. DNA from normal tissue from the patients with replication errors was screened for germ-line mutations of the mismatch-repair genes MLH1 and MSH2.

Results Among the 509 patients, 63 (12 percent) had replication errors. Specimens of normal tissue from 10 of these 63 patients had a germ-line mutation of MLH1 or MSH2. Of these 10 patients (2 percent of the 509 patients), 9 had a first-degree relative with endometrial or colorectal cancer, 7 were under 50 years of age, and 4 had had colorectal or endometrial cancer previously.

Conclusions In this series of patients with colorectal cancer in Finland, at least 2 percent had hereditary nonpolyposis colorectal cancer. We recommend testing for replication errors in all patients with colorectal cancer who meet one or more of the following criteria: a family history of colorectal or endometrial cancer, an age of less than 50 years, and a history of multiple colorectal or endometrial cancers. Patients found to have replication errors should undergo further analysis for germ-line mutations in DNA mismatch-repair genes.


Source Information

From the Departments of Medical Genetics (L.A.A., R.S., P.K., F.C., A.H., P.P., A.C.) and Pathology (R.S.), Haartman Institute, University of Helsinki, Helsinki, Finland; Applied Biosystems Division, Perkin–Elmer Corporation, Foster City, Calif. (R.B.C.); the Human Cancer Genetics Program, Comprehensive Cancer Center, Ohio State University, Columbus (R.B.C., A.C.); the Family Federation of Finland, Helsinki (H.K.); the Department of Surgery, Central Hospital of Jyväskylä, Jyväskylä, Finland (J.-P.M.); the Department of Surgery, Kuopio University Hospital, Kuopio, Finland (M.E.); and the Second Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland (H.J.). Other authors were Antonio Percesepe, M.D. (Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki), Heikki Ahtola, M.D. (Department of Surgery, Central Hospital of Joensuu, Joensuu), Niilo Härkönen, M.D. (Department of Surgery, Central Hospital of Mikkeli, Mikkeli), Risto Julkunen, M.D. (Department of Internal Medicine, Kuopio University Hospital, Kuopio), Eero Kangas, M.D. (Department of Surgery, Central Hospital of Lappenranta, Lappenranta), Seppo Ojala, M.D. (Department of Surgery, Central Hospital of Kajaani, Kajaani), Jukka Tulikoura, M.D. (Department of Surgery, Central Hospital of Kotka, Kotka), and Erkki Valkamo, M.D. (Department of Surgery, Central Hospital of Savonlinna, Savonlinna) — all in Finland.

Address reprint requests to Dr. Aaltonen at the Department of Medical Genetics, Haartman Institute, P.O. Box 21, FIN-00014 University of Helsinki, Helsinki, Finland.

Full Text of this Article


Related Letters:

Molecular Diagnosis of Hereditary Nonpolyposis Colon Cancer
Guillem J. G., Aaltonen L. A., Mecklin J.-P., de la Chapelle A.
Extract | Full Text  
N Engl J Med 1998; 339:924-925, Sep 24, 1998. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.